April 24 (Reuters) - Carmat SA ALCAR.PA :
* 2023 SALES OF €2.8 MILLION, I.E. 17 AESON® IMPLANTS,
INCLUDING
11 IN THE LAST QUARTER
* 12-MONTH FINANCING REQUIREMENTS ESTIMATED AT AROUND €45
MILLION
* 2024 SALES FORECAST OF AROUND €14 MILLION
* ACTIVE EXPLORATION OF FINANCING OPTIONS TO EXTEND, IN THE
SHORT-TERM, THE COMPANY'S FINANCIAL HORIZON BEYOND MAY 2024
* FY NET LOSS EUR 53.9 MILLION VERSUS LOSS OF EUR 53.7
MILLION
YEAR AGO
* FY NET OPERATING EXPENSES EUR -52.5 MILLION VERSUS EUR
-51.9
MILLION YEAR AGO
* END-DEC CASH POSITION AT €8.0 MILLION (VERSUS €51.4
MILLION AT
THE END OF 2022)
Source text for Workspace: ID:nFWN3GX037
Further company coverage: ALCAR.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))